Verition Fund Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.64M | Buy |
115,408
+80,005
| +226% | +$3.91M | 0.03% | 773 |
|
|
2025
Q1 | $1.8M | Sell |
35,403
-6,483
| -15% | -$330K | 0.01% | 1272 |
|
|
2024
Q4 | $1.89M | Buy |
41,886
+9,152
| +28% | +$413K | 0.01% | 1191 |
|
|
2024
Q3 | $1.21M | Buy |
32,734
+1,669
| +5% | +$61.9K | 0.01% | 1222 |
|
|
2024
Q2 | $950K | Buy |
31,065
+7,485
| +32% | +$229K | 0.01% | 1187 |
|
|
2024
Q1 | $686K | Sell |
23,580
-980
| -4% | -$28.5K | ﹤0.01% | 1321 |
|
|
2023
Q4 | $677K | Sell |
24,560
-674
| -3% | -$18.6K | 0.01% | 1029 |
|
|
2023
Q3 | $565K | Sell |
25,234
-1,687
| -6% | -$37.8K | 0.01% | 1136 |
|
|
2023
Q2 | $1.09M | Buy |
26,921
+3,897
| +17% | +$158K | 0.01% | 774 |
|
|
2023
Q1 | $1.12M | Sell |
23,024
-693
| -3% | -$33.6K | 0.02% | 818 |
|
|
2022
Q4 | $905K | Sell |
23,717
-1,057
| -4% | -$40.3K | 0.01% | 802 |
|
|
2022
Q3 | $1.24M | Sell |
24,774
-2,035
| -8% | -$102K | 0.01% | 1027 |
|
|
2022
Q2 | $1.07M | Buy |
+26,809
| New | +$1.07M | 0.02% | 950 |
|
|
2021
Q2 | – | Sell |
-8,227
| Closed | -$390K | – | 1941 |
|
|
2021
Q1 | $390K | Buy |
+8,227
| New | +$390K | ﹤0.01% | 880 |
|
|
2020
Q1 | – | Sell |
-25,274
| Closed | -$1.21M | – | 849 |
|
|
2019
Q4 | $1.21M | Buy |
+25,274
| New | +$1.21M | 0.02% | 315 |
|
|
2019
Q3 | – | Sell |
-47,306
| Closed | -$2.13M | – | 1149 |
|
|
2019
Q2 | $2.13M | Buy |
+47,306
| New | +$2.13M | 0.06% | 184 |
|
|
2018
Q2 | – | Sell |
-14,006
| Closed | -$379K | – | 1187 |
|
|
2018
Q1 | $379K | Buy |
+14,006
| New | +$379K | 0.03% | 682 |
|